AJ
BIIB icon

Ashburton (Jersey)’s Biogen BIIB Stock Holding History

Ashburton (Jersey)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,554
Closed -$1.01M – 56
2016
Q4 		$1.01M Sell
3,554
-85
-2% -$25.2K 0.43% 52
2016
Q3 		$1.14M Sell
3,639
-3,328
-48% -$986K 0.52% 51
2016
Q2 		$1.69M Sell
6,967
-2,441
-26% -$643K 0.7% 40
2016
Q1 		$2.45M Sell
9,408
-585
-6% -$155K 0.86% 33
2015
Q4 		$3.08M Buy
+9,993
New +$2.87M 0.82% 36

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ashburton (Jersey)'s BIIB Position: Q1 2017 in Review

Ashburton (Jersey) sold out of Biogen (BIIB) in Q1 2017, closing a stake of 3,554 shares — an estimated $1.01M sold.

Ashburton (Jersey) first reported a position in BIIB in Q4 2015 and held it in 5 quarters. The position peaked at $3.08M in Q4 2015. 1,020 funds tracked by Wall St. Rank hold BIIB as of Q1 2017.

  • Ashburton (Jersey) reported no remaining Biogen position as of Q1 2017 after selling out during the quarter.
  • Ashburton (Jersey) sold 3,554 Biogen shares in Q1 2017, an estimated $1.01M.
  • Ashburton (Jersey) first reported a position in Biogen in Q4 2015 and held it in 5 quarters.
  • Ashburton (Jersey)'s Biogen position peaked at $3.08M in Q4 2015.
  • 1,020 funds tracked by Wall St. Rank held Biogen as of Q1 2017.

Based on Ashburton (Jersey)'s 13F filing for Q1 2017, filed 18 May 2017.